Clarium Secures $27M to Enhance AI Supply Chain Platform
Clarium has raised $27 million in a Series A funding round led by Northzone to scale its AI-powered supply chain resiliency platform for healthcare systems.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Clarium has raised $27 million in a Series A funding round led by Northzone to scale its AI-powered supply chain resiliency platform for healthcare systems.
The AI in Pathology Market is projected to grow from $87.2 million in 2024 to $347.4 million by 2030, driven by advancements in digital pathology and telepathology.
Petfolk has selected Radimal as its exclusive teleradiology provider, integrating AI-powered radiology and specialist support across its U.S. clinics.
ACTO has appointed Lori Tierney, former President of Johnson & Johnson Vision, to its Board of Directors to enhance its AI-first platform in life sciences.
The Global Ovarian Cancer Research Consortium has partnered with Microsoft's AI for Good Lab to launch a $1 million grant aimed at improving ovarian cancer survival rates.
OpenAI has engaged in discussions with the FDA about using AI to expedite drug evaluations, focusing on a project called cderGPT.
Phenomix Sciences and Mayo Clinic have developed an AI algorithm to predict nausea risk from GLP-1 therapies, enhancing personalized obesity care.
Carta Healthcare has raised $18.25 million in Series B1 funding to enhance its AI-driven clinical data abstraction and analytics services, announced in a press release.
ODAIA has announced a new AI-powered marketing orchestration solution for pharma, enhancing personalized engagement with healthcare professionals.
HighPeak, backed by Prudential, has launched an AI-driven platform to provide financial advisors with precise forecasts of healthcare costs, as announced in a press release.
Benchling and Moderna have announced an expanded collaboration to integrate AI-driven research across Moderna's R&D operations, enhancing scientific workflows and data management.
Zilia Inc. has closed a bridge financing round with participation from Linearis Ventures and existing investors to advance its oculomics platform.
Inductive Bio has raised $25 million in Series A funding to enhance its AI platform for small molecule drug discovery, announced in a press release. The funding round was led by Obvious Ventures with participation from Andreessen Horowitz and Lux Capital.
Persivia has announced a $107 million investment from Aldrich Capital Partners and a new patent for its AI-driven Health Data Processing System.
Mana.bio has presented new data at the ASGCT 2025 Annual Meeting, highlighting its AI-driven platform for optimizing lipid nanoparticle design for RNA therapies.
ECOSEP and Tata Elxsi have announced a strategic partnership to integrate AI into sports medicine, focusing on diagnostics and personalized care.
FutureHouse has introduced Finch, an AI tool designed to facilitate data-driven discoveries in biology, as announced by the nonprofit organization.
Spring Health has announced the launch of VERA-MH, an open-source benchmark for evaluating AI in mental health, aimed at ensuring ethical and safe AI interactions.
Altamont Software has successfully integrated AI-powered radiology reporting applications with existing imaging modalities, enhancing efficiency in medical imaging processes.
H. Lundbeck A/S has partnered with the Danish Centre for AI Innovation to utilize the Gefion AI supercomputer for advancing drug discovery in neurological and psychiatric disorders.